Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Fatigue × Zoledronic Acid × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Fatigue 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Therapeutics 8 Surveys and Questionnaires 5 Psychiatric Rehabilitation 3 Mental Status and Dementia Tests 3 Interviews as Topic 2 Gene Expression Profiling 2 Enzyme-Linked Immunosorbent Assay 2 Drug Therapy 2 Amplified Fragment Length Polymorphism Analysis 2 radium Ra 223 dichloride 1 enzalutamide 1 darolutamide 1 apalutamide 1 Zoledronic Acid 1 Trastuzumab 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radium-223 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Radiation 1 Polymerase Chain Reaction 1 Neuropsychological Tests 1 Microarray Analysis 1 Metformin 1 Mass Spectrometry 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Karnofsky Performance Status 1 Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04488614 2020-07-30

PBCB

Helse Stavanger HF

Enrolling by invitation

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡